{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:14:07Z","timestamp":1761279247221,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.7759\/cureus.95266","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:09:18Z","timestamp":1761278958000},"source":"Crossref","is-referenced-by-count":0,"title":["De Novo Myeloid Sarcoma of the Kidney: A Case Report and Literature Review of Clinical Features and Outcomes"],"prefix":"10.7759","author":[{"given":"Jie","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherryn","family":"Sherryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bagus","family":"Baskoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri SA","year":"2007","unstructured":"Pileri SA, Ascani S, Cox MC, et al.. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007, 21:340-50. 10.1038\/sj.leu.2404491","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19.","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.11.004","article-title":"Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival","volume":"22","author":"Werstein B","year":"2020","unstructured":"Werstein B, Dunlap J, Cascio MJ, Ohgami RS, Fan G, Press R, Raess PW. Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival. J Mol Diagn. 2020, 22:338-45. 10.1016\/j.jmoldx.2019.11.004","journal-title":"J Mol Diagn"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04313-x","article-title":"Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow","volume":"100","author":"Engel NW","year":"2021","unstructured":"Engel NW, Reinert J, Borchert NM, et al.. Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow. Ann Hematol. 2021, 100:499-503. 10.1007\/s00277-020-04313-x","journal-title":"Ann Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2012.10.014","article-title":"Is there a \"gold\" standard treatment for patients with isolated myeloid sarcoma?","volume":"67","author":"Antic D","year":"2013","unstructured":"Antic D, Elezovic I, Milic N, et al.. Is there a \"gold\" standard treatment for patients with isolated myeloid sarcoma?. Biomed Pharmacother. 2013, 67:72-7. 10.1016\/j.biopha.2012.10.014","journal-title":"Biomed Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond LM","year":"2017","unstructured":"Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk. 2017, 17:263-7. 10.1016\/j.clml.2017.02.027","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2013.008","article-title":"The CARE Guidelines: consensus-based clinical case reporting guideline development","volume":"2","author":"Gagnier JJ","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE Guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013, 2:38-43. 10.7453\/gahmj.2013.008","journal-title":"Glob Adv Health Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis RM","year":"2021","unstructured":"Shallis RM, Gale RP, Lazarus HM, et al.. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved. Blood Rev. 2021, 47:100773. 10.1016\/j.blre.2020.100773","journal-title":"Blood Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5858\/2006-130-862-MSOTUB","article-title":"Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16)","volume":"130","author":"Al-Quran SZ","year":"2006","unstructured":"Al-Quran SZ, Olivares A, Lin P, Stephens TW, Medeiros LJ, Abruzzo LV. Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16). Arch Pathol Lab Med. 2006, 130:862-6. 10.5858\/2006-130-862-MSOTUB","journal-title":"Arch Pathol Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/861232","article-title":"Nonleukemic ureteral granulocytic sarcoma presenting with unilateral urinary obstruction and hematuria","volume":"2013","author":"Acar O","year":"2013","unstructured":"Acar O, Esen T, Tecimer T, Cetiner M, Peker O, Musao\u011flu A. Nonleukemic ureteral granulocytic sarcoma presenting with unilateral urinary obstruction and hematuria. Case Rep Urol. 2013, 2013:861232. 10.1155\/2013\/861232","journal-title":"Case Rep Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)01750-8","article-title":"Primary granulocytic sarcoma of the urinary bladder: case report and review of the literature","volume":"60","author":"Aki H","year":"2002","unstructured":"Aki H, Baslar Z, Uygun N, Ozguroglu M, Tuzuner N. Primary granulocytic sarcoma of the urinary bladder: case report and review of the literature. Urology. 2002, 60:345. 10.1016\/s0090-4295(02)01750-8","journal-title":"Urology"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/0090-4295(84)90173-0","article-title":"Hematologic neoplasms with initial manifestations in lower urinary tract","volume":"23","author":"Chaitin BA","year":"1984","unstructured":"Chaitin BA, Manning JT, Ord\u00f3\u00f1ez NG. Hematologic neoplasms with initial manifestations in lower urinary tract. Urology. 1984, 23:35-42.","journal-title":"Urology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1990.tb14842.x","article-title":"Granulocytic sarcoma (chloroma) of the kidney and prostate","volume":"65","author":"Chan YF","year":"1990","unstructured":"Chan YF. Granulocytic sarcoma (chloroma) of the kidney and prostate. Br J Urol. 1990, 65:655-6. 10.1111\/j.1464-410x.1990.tb14842.x","journal-title":"Br J Urol"},{"key":"ref15","article-title":"Unusual presentation of bladder myeloid sarcoma causing acute renal failure: case report and review of the literature","volume":"11","author":"John S","year":"2013","unstructured":"John S, Ahmad HA, Dunn T, Kern W, Holter J, Cherry M. Unusual presentation of bladder myeloid sarcoma causing acute renal failure: case report and review of the literature. Clin Adv Hematol Oncol. 2013, 11:388-93.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04013-6","article-title":"A rare case of donor-derived promyelocytic sarcoma in a kidney transplant recipient","volume":"100","author":"Liu J","year":"2021","unstructured":"Liu J, Shen L, Huang H, Gao X, Mou S, Ying L, Yin T. A rare case of donor-derived promyelocytic sarcoma in a kidney transplant recipient. Ann Hematol. 2021, 100:295-6. 10.1007\/s00277-020-04013-6","journal-title":"Ann Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.1870120712","article-title":"Chloroma of the urinary bladder: sonographic findings","volume":"12","author":"McLeod AJ","year":"1984","unstructured":"McLeod AJ, Lewis E, Cox D. Chloroma of the urinary bladder: sonographic findings. J Clin Ultrasound. 1984, 12:434-5. 10.1002\/jcu.1870120712","journal-title":"J Clin Ultrasound"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3604298","article-title":"Primary myeloid sarcoma of the prostate: a case report and literature review","volume":"2018","author":"Nguyen R","year":"2018","unstructured":"Nguyen R, Sayar H. Primary myeloid sarcoma of the prostate: a case report and literature review. Case Rep Hematol. 2018, 2018:3604298. 10.1155\/2018\/3604298","journal-title":"Case Rep Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/821346","article-title":"Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor","volume":"2015","author":"Palanisamy A","year":"2015","unstructured":"Palanisamy A, Persad P, Koty PP, et al.. Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Case Rep Nephrol. 2015, 2015:821346. 10.1155\/2015\/821346","journal-title":"Case Rep Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20022","article-title":"Granulocytic sarcoma of the urinary bladder","volume":"75","author":"Hasegeli Uner A","year":"2004","unstructured":"Hasegeli Uner A, Altundag K, Saglam A, Tekuzman G. Granulocytic sarcoma of the urinary bladder. Am J Hematol. 2004, 75:262-3. 10.1002\/ajh.20022","journal-title":"Am J Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0903-0","article-title":"Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney","volume":"34","author":"Wong RL","year":"2020","unstructured":"Wong RL, Ketcham M, Irwin T, et al.. Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney. Leukemia. 2020, 34:2776-9. 10.1038\/s41375-020-0903-0","journal-title":"Leukemia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-021-01141-z","article-title":"Case report: rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations","volume":"16","author":"Wu D","year":"2021","unstructured":"Wu D, Lu X, Yan X, Gao R. Case report: rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations. Diagn Pathol. 2021, 16:82. 10.1186\/s13000-021-01141-z","journal-title":"Diagn Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni B","year":"2011","unstructured":"Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2011, 2:309-16. 10.1177\/2040620711410774","journal-title":"Ther Adv Hematol"},{"key":"ref24","article-title":"Granulocytic sarcoma: a systematic review","volume":"3","author":"Yilmaz AF","year":"2013","unstructured":"Yilmaz AF, Saydam G, Sahin F, Baran Y. Granulocytic sarcoma: a systematic review. Am J Blood Res. 2013, 3:265-70.","journal-title":"Am J Blood Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861215)58:12<2697::aid-cncr2820581225>3.0.co;2-r","article-title":"Granulocytic sarcoma in nonleukemic patients","volume":"58","author":"Meis JM","year":"1986","unstructured":"Meis JM, Butler JJ, Osborne BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer. 1986, 58:2697-709. 10.1002\/1097-0142(19861215)58:12&lt;2697::aid-cncr2820581225&gt;3.0.co;2-r","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03653.x","article-title":"Bladder chloroma complicating refractory anaemia with excess of blasts","volume":"118","author":"Kerr P","year":"2002","unstructured":"Kerr P, Evely R, Pawade J. Bladder chloroma complicating refractory anaemia with excess of blasts. Br J Haematol. 2002, 118:688. 10.1046\/j.1365-2141.2002.03653.x","journal-title":"Br J Haematol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan TY","year":"2009","unstructured":"Lan TY, Lin DT, Tien HF, Yang RS, Chen CY, Wu K. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol. 2009, 122:238-46. 10.1159\/000253592","journal-title":"Acta Haematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd JC","year":"1997","unstructured":"Byrd JC, Weiss RB, Arthur DC, et al.. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol. 1997, 15:466-75. 10.1200\/JCO.1997.15.2.466","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou AM","year":"2008","unstructured":"Tsimberidou AM, Kantarjian HM, Wen S, et al.. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008, 113:1370-8. 10.1002\/cncr.23691","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415563-de-novo-myeloid-sarcoma-of-the-kidney-a-case-report-and-literature-review-of-clinical-features-and-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:09:22Z","timestamp":1761278962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415563-de-novo-myeloid-sarcoma-of-the-kidney-a-case-report-and-literature-review-of-clinical-features-and-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.95266","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}